257 CHEMORADIOTHERAPY FOLLOWED BY ACTIVE SURVEILLANCE VERSUS SURGERY FOR ESOPHAGEAL CANCER: A SYSTEMATIC REVIEW AND INDIVIDUAL PATIENT DATA META-ANALYSIS
Bernadetta Wilk(Erasmus MC), JJB van Lanschot(Erasmus MC), S Kim(Asan Medical Center), Daan Nieboer(Erasmus MC), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), J Kim(Asan Medical Center), Heidi Furlong(The University of Texas MD Anderson Cancer Center), T. N. Walsh(Connolly Hospital Blanchardstown), Sjoerd M. Lagarde(University of Amsterdam), Rita Alfieri(Istituto Oncologico Veneto), Ben M. Eyck(Erasmus MC Cancer Institute), Carlo Castoro(Humanitas University), Wayne L. Hofstetter(The University of Texas MD Anderson Cancer Center), Jaffer A. Ajani(The University of Texas MD Anderson Cancer Center), Guillaume Piessen(Centre Hospitalier Universitaire de Lille)
Cited by 3
Related Papers
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.7k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.1k
A calibration hierarchy for risk models was defined: from utopia to empirical data
|Journal of Clinical Epidemiology|2016|834
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788